Seeking Alpha

Galena Biopharma -17% after report rips painkiller drug sample giveaway

  • Galena Biopharma (GALE -16.9%) plunges after Bronte Capital's John Hempton ridicules the company for marketing its fentanyl-based painkiller Abstral with free samples - "a new low in the pharmaceutical industry."
  • GALE's giveaway is "evil," Hempton writes; it's "doing hippie alternative lifestyle drug marketing for drugs that are especially effective in turning you into a zombie."
  • Adam Feuerstein reminds investors that when examining Q4 and 2013 results, "market share gains derived from free samples don't mean much."
  • Matt Gravitt recently posted his own negative critique on SA, highlighting "numerous red flags" which suggest a "significant overvaluation."
Comments (46)
  • deercreekvols
    , contributor
    Comments (6711) | Send Message
     
    Noble Financial lifted its price target on Galena this morning.
    http://bit.ly/1fFpIkV
    This could have been added to the news on GALE, in my opinion.

     

    Mr. Gravitt is short GALE.
    Mr. Gravitt is ChetStedman5 on twitter.
    ChetStedman5 was in contact with Adam Feuerstein on the Street.com's Biotech Stock Mail bag just a few days before Mr. Gravitt's Red Flag article.
    3 Feb 2014, 11:54 AM Reply Like
  • Ljsco
    , contributor
    Comments (9) | Send Message
     
    To begin with, they're not giving the samples away to the public. Most drug companies give away free samples to doctors, hospitals, etc. when introducing a new product. That's how the marketing is done, it's the nature of the business. I guess Galena has fallen from grace and negative articles can be misleading. If you're going to state your case on a stock, stick to relevant criticism.
    3 Feb 2014, 11:56 AM Reply Like
  • billeebong
    , contributor
    Comments (178) | Send Message
     
    ...are you serious? There is not a drug company around that does not do the same thing...incredible.
    3 Feb 2014, 12:01 PM Reply Like
  • karmaswimswami
    , contributor
    Comments (125) | Send Message
     
    In fact you are completely wrong billeebong and ljsco. This is the only instance I have even encountered of a drug company sampling a narcotic. I would ban any such samples from my office. It is irresponsible, negligent, obscene, for a company to be doing this, as company reps have no way of securing the samples. They walk away, get stolen, even get swiped by a clinic's staff.

     

    I have been predicting the fall of GALE for quite some time here. It is bizarre to me for a biotech company to be acquiring rights to sublingual fentanyl. It is neither novel nor new. It has high street value and abuse potential, is rarely indicated, and is available in many other forms, such as the Actiq fentanyl lollipop. It is unreasonable to prescribe it for any but extraordinary cancer pain, and there only after a patient has demostrated extreme opiate tolerance and refractoriness.

     

    Sampling fentanyl was an inane asinine idea. Shame on Galena,
    3 Feb 2014, 01:42 PM Reply Like
  • Bryce_in_TX
    , contributor
    Comments (3610) | Send Message
     
    karma,
    It looks to me like you have to get the drug from a pharmacy, not a doctor's office. You simply get it free in the first month, instead of paying for it. It appears to me there is no loss of control of the controlled substance. I assume the pharmacy keeps track of it as it normally would. No sales reps involved that I see.
    http://bit.ly/1etcSqg
    I don't follow the inappropriateness of allowing patients to obtain a very expensive, prescribed drug, for a lessor cost.
    If the doctor writes the script, what's the big deal?
    Drug companies have patient assistance programs for those who can't afford to pay for a med.
    What is the ethical breach here? I'm not seeing it.

     

    Are you a nurse or medical professional?
    3 Feb 2014, 02:07 PM Reply Like
  • ftwitty
    , contributor
    Comments (50) | Send Message
     
    LOL -- they aren't giving it away like that! OMG They are giving it ONLY to patients who need it. No patient will pay that kind of money (yep, it's expensive) for something until they try it and it's proven to work for their needs. It is doctor prescribed and controlled. You really think they are standing on a street corner offering it to every passerby? Kids maybe? LOL This is marketing 101, narcotic or not, directed to their target audience. Let the folks who need it, really NEED it, try it, see if it works, so they can compare against the drug(s) they are already on. It's a great idea and as a patient in pain, I'm sure I'd appreciate my portion being gratis for the first time so I can see how it compares to the drug(s) I would probably already be on. Then, if it works well, and I tell my doctor about it, HE/SHE tells other patients that some of his/her patients have found success with it. And so on, and so on, etc. Brilliant of GALE!
    4 Feb 2014, 12:49 AM Reply Like
  • Zubunda
    , contributor
    Comments (168) | Send Message
     
    U Mad Bro?
    4 Feb 2014, 08:57 AM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    Yep, you got that right. Not just any pharmacy, not to be redundant, but seems I need to be but one that is approved, via stringent review and continual tracking, just as the patient and prescribing physician, by the FDA, under the TIRF/REMS program.

     

    Thank you for standing up to this same attempt to mislead and manipulate everywhere these posters write, then we spread knowledge to those who don't know, I hope will never know for the reasons I do.
    4 Feb 2014, 10:53 AM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    Again, no way you are a doctor because you would know that such a "sample" requires a DEA triplicate script from a physician, the treating Oncologist or Pain specialist (again that is a part of the FDA's TRIF/REMS program) that works in conjunction with the treating Oncologist which again the physician, pharmacy and patient all must be under the TRIF/REMS program). The vetted patient then takes the triplicate script, which the DEA receives a copy of, and must locate a participating TRIF/REMS pharmacy (few are) and only then, with your driver's license or other ID will the sample script be filled. These posts are irresponsible because they do not represent the facts. When you suffer from intractable pain in addition to 6-8 episodes of crippling, debilitating pain may you comment on the efficacy of fentanyl. Abstral takes affect in 5-10 min. maximum and matches the duration of the 30 minute (on average) pain episode allowing patients to stay away from breakthrough medications that last too long and don't combat this particular type of pain. Fentanyl is not heroin, Philip Seymour Hoffman was a tragic victim of drug abuse and was found with a needle sticking out of his arm. A search of his residence turned up 50 bags of fentanyl laced heroin, he apparently liked his heroin this way. That has no place in this "discussion" and if by chance you really are a physician, I sure hope your patients have the expertise of an excellent Oncologist or pain doctor who works in conjunction with your cancer patients because they have a right to palliative care. Not your bias against a particular class of medications that you lack the pre-requisite experience with, in fact, you should not even get a DEA script pad, leave it to the experts. The Atiq lollipop you refer to, in fact all generic TRIF drugs are not sugar free and are known to cause severe dental decay, these were in fact developed for children requiring anesthesia, the "yummy" lollipop was a way to get them to sleep before putting their IV in, it was never designed for this type of use and again, does not match the modality of Abstral. To further reiterate, Abstral patients must already be on long-acting pain medications before qualifying for use, demonstrating opioid tolerance and the need for additional pain medication to treat malignant break through pain. However, I do know of a sickle cell patient that uses Abstral and I believe they have every right to use it as they deal with rapid cycling pain of an extraordinary level and to deny such use would be discriminatory, and not based on race, but disease because there are other debilitating diseases that lack the marketing and empathy that cancer evokes. Shame on you, GOD BLESS Galena.
    10 Feb 2014, 01:44 AM Reply Like
  • Bryce_in_TX
    , contributor
    Comments (3610) | Send Message
     
    "Again, no way you are a doctor because you would know that such a "sample" requires a DEA triplicate script from a physician,"
    It certainly sounds fishy. As a pharmacist tech I was aware of the triplicate script since we filled some of these types of RXs. Because this is a highly controlled drug, Schedule II, samples comment just didn't fly, so I looked at the actual coupon from GALE. We were required to keep all Schedule II drugs in a locked safe at the pharmacy I worked at.
    You would think any Doctor would know these facts:
    "For products in Schedule II, prescribers cannot phone in prescriptions to pharmacies for their patients, according to the letter from APhA and other pharmacy groups. That products in Schedule II cannot be refilled without a new prescription means that patients “who may have mobility limitations or chronic pain could now be required to travel long distances and suffer significant discomfort to see their physician for refills and to have their prescriptions filled"
    "The joint letter explained that pharmacies stock dozens of different hydrocodone products, and that rescheduling would impose new requirements related to secure storage, recordkeeping, and inventory management. Depending on state law, pharmacies would be required 'to maintain a perpetual inventory on these products, which would mean literally counting each Schedule II tablet in storage on a regular basis.' Ordering requirements for Schedule II products are 'much more burdensome' than non–Schedule II products, and federal law also requires that separate files be kept in the pharmacy for these products.
    Rescheduling also carries logistical considerations. For example, the joint letter continued, “many pharmacies would likely be forced to purchase and install significantly larger safes, which are costly and consume a large amount of the limited space within a pharmacy.' "
    http://bit.ly/M5NHPW
    (1) Schedule II drugs must be kept in a pharmacy safe
    (2) A regular inventory count and tight inventory control is required on Schedule II drugs.

     

    (3) A pharmaceutical rep doesn't have samples of Schedule II drugs to hand out to physicians.
    karmaswimswami's post:
    "I would ban any such samples from my office. It is irresponsible, negligent, obscene, for a company to be doing this, as company reps have no way of securing the samples. They walk away, get stolen, even get swiped by a clinic's staff."
    Karma, this is why I asked you if you were a nurse or medical professional. It certainly doesn't appear that way to me. You weren't even aware of the stringent control, at multiple levels, on Schedule II drugs. Who are you and what is your real background?
    10 Feb 2014, 12:41 PM Reply Like
  • Bryce_in_TX
    , contributor
    Comments (3610) | Send Message
     
    ""I would ban any such samples from my office. It is irresponsible, negligent, obscene, for a company to be doing this, as company reps have no way of securing the samples. They walk away, get stolen, even get swiped by a clinic's staff."
    You aren't a doctor but you play one on SA. Is that it? Better read up "Doc".
    " A DEA Form 222 is required for each distribution, purchase, or transfer of a schedule II controlled substance."
    http://bit.ly/1eOifk0
    Not only that, but Schedule II substances are highly controlled and required to be locked up on the premises. The idea that the Abstral is going to be given to pharmaceutical reps for handing out to doctors' offices/clinics is laughable.
    10 Feb 2014, 02:53 PM Reply Like
  • deercreekvols
    , contributor
    Comments (6711) | Send Message
     
    If Bronte Capital is going to "rip" Galena, then they better "rip" every other drug company out there.
    What's that?
    They are only short Galena?
    Now it makes sense....
    3 Feb 2014, 12:05 PM Reply Like
  • Zankudo
    , contributor
    Comments (232) | Send Message
     
    Looks like a coordinated effort on the part of these 3 which has worked…for the moment. But time will tell on GALE. There are 7 analysts, count 'em, 7 who ALL recommend buying GALE with price targets at 6 or higher. I am sure they are at least as knowledgeable as these 3. The complaints are de minimis. The drug give-away is normal.
    3 Feb 2014, 12:08 PM Reply Like
  • chongkim74
    , contributor
    Comments (1195) | Send Message
     
    Im not trying to be a bull for GALE, I have my money in it and I believe in this company...but this blog by Bronte Capital was the most ridiculous piece Ive heard this year. I dont believe this writer got the green light to write such a bogus statements...So pretty much all the pharma cos in the world that provided free samples for their new and old product is a crack dealer and that concludes the product being a failure?!?! I have so much products that launched with free samples in my head that I dont have enough time to list it. Give me a break. So much hedgers and shorters in the stock its not even funny. Im actually allocating my F stocks as we speak to get in more...
    3 Feb 2014, 12:11 PM Reply Like
  • vanebfbc
    , contributor
    Comments (113) | Send Message
     
    Manipulation at its best. "Assigned with prescription" is not "given free to the public" and chemo-treated patient is not "new-age styled woman". As an investor with no position in GALE I don't put emotions in something like this, but sometimes you have to wonder how far some people will go to hurt others (company, doctors, patients, investors, etc.) just so they can make quick bucks.
    3 Feb 2014, 12:14 PM Reply Like
  • Bryce_in_TX
    , contributor
    Comments (3610) | Send Message
     
    Hempton also wrote negatively about Linn Energy and got his butt handed to him by shorting them. Here's hoping for number two.
    3 Feb 2014, 12:22 PM Reply Like
  • Gman123456
    , contributor
    Comments (36) | Send Message
     
    I have E-mail out to Mark J Aha and Steven Kriegsman . Any one get anything from them.
    3 Feb 2014, 12:41 PM Reply Like
  • tommy1954
    , contributor
    Comments (65) | Send Message
     
    checkout RegardedSolutions Instablog on SA. He will be interviewing Mark Ahn soon.
    4 Feb 2014, 06:06 AM Reply Like
  • jonomatic_2000
    , contributor
    Comments (35) | Send Message
     
    Gale you have to regain traction.
    3 Feb 2014, 12:50 PM Reply Like
  • russleehowe
    , contributor
    Comments (75) | Send Message
     
    Manipulators win this round. Short sellers with a coordinated attack on GALE are smiling. I sold half early last week and the rest at the open today down 12%. I am now back in at about 20% off Friday's close. All those of us who are long will, in my humble opinion, come out on top.
    3 Feb 2014, 12:53 PM Reply Like
  • WilsonWagwa
    , contributor
    Comments (64) | Send Message
     
    I will say it again this concerted effort by The Street.Con (Crummer Farstain) and these other short players have an agenda to destroy the share price for their own benefit. Barclays and real investors are not in agreement with these low life clowns because they own millions of shares.
    3 Feb 2014, 12:53 PM Reply Like
  • Zubunda
    , contributor
    Comments (168) | Send Message
     
    Dudes you have got to learn how to read!! They are not grouponing the drug, just providing free samples/and co-pay to patients whose doctors have already prescribed the drug to them!! Standard market practice!!!! Don't you guys think that the bears would base their thesis on dismal sales (as they have access to IMS and Symphony) if it were the case? My prediction is that the sales of the drug are going to be stellar, no matter how you feel about the company!!

     

    PS check out the competitor INSYS a 1,2 Bln company, see what they are offering:
    "Patient Co-Pay Savings Program

     

    Start saving with the SUBSYS Effective Dose Savings Program. Patients can receive free product and up to $500 off each additional prescription. This program is for commercially insured and cash paying patients only." Source: http://bit.ly/1et4Ld6 -Sound familiar?!?!
    3 Feb 2014, 12:54 PM Reply Like
  • Regarded Solutions
    , contributor
    Comments (17900) | Send Message
     
    This is absurd, my daughter works for Henry Schein, and she visits dentists with free samples of everything, a friend works for Gilead, and he wouldn't dare walk into a doctors office without free something!

     

    The entire premise here is to drive the price down, maybe Cramer will tout it again at HIS price like he did back in December I think it was....oh wait isn't AF associated with JC????? Hmmmmm, and didn't Matt Gravitts lie about not actually being Chet Stedman, and having conversations with AF?

     

    Or am I just being paranoid.

     

    The sales of Abstral are happening, they reported 1.2 million and we shall see what this quarter brings.
    3 Feb 2014, 12:55 PM Reply Like
  • Gman123456
    , contributor
    Comments (36) | Send Message
     
    Any word from Galena on this I seed Email with no reply. I have got reply in the past.
    3 Feb 2014, 01:18 PM Reply Like
  • ftwitty
    , contributor
    Comments (50) | Send Message
     
    Did he actually lie about being Chet Stedman? I didn't see this. I believe I am the one who outed his true identify, IF in fact it IS his true identity. For all we know, he's AF himself! ;) :) My post was, of course, deleted.
    4 Feb 2014, 12:56 AM Reply Like
  • Regarded Solutions
    , contributor
    Comments (17900) | Send Message
     
    yes he did lie but tried to cover it up I believe.
    4 Feb 2014, 01:26 AM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    As were more of mine than I can site that were NOT in the slightest bit offensive, just clearly threatened Matt's position. As I've said before, wonder why he suppressed my right to have an opposing view? Hmmm, wonder why that could be, oh b/c he knew the moderators didn't have time to review the number of comments coming in so he could keep slamming and shorting via information that benefited his cause.
    4 Feb 2014, 11:00 AM Reply Like
  • Bleecker Street Research
    , contributor
    Comments (493) | Send Message
     
    RS, I think you are off here. Many many people use pseudonyms on twitter. I don't tweet under my own name. And most of the people I interact with don't either. He didn't lie about who he was, he says he is chet steadman in his SA bio. Also worth noting that Chet Steadman is a character in Rookie of the Year. Where do you think he lied about it? All I see is him asking AF a question that showed up in the mailbag.
    4 Feb 2014, 01:59 PM Reply Like
  • Kboyd78
    , contributor
    Comments (159) | Send Message
     
    It's very enjoyable to listen to finance experts attempt to talk about drugs and medicine as if they know anything. As a doctor I get some great laughs listening the to the pseudo intellectual non sense that comes from so called finance "experts". This report was clearly filed by a simpleton. Medicine samples have been given out for years and as a true professional who uses fentanyl in my practice every day I can assure that the narcotic analgesic fentanyl is not something that will cause a walking dead effect on its population. It does, however, do a great job of helping people with real pain get some relief. When I hear people who literally know nothing about medicine or drugs make stupid blanket statements I can't help but wonder are they really idiots as they appear or do they have an agenda. Kind of interesting this statement coincides with the short article put out on SA Friday. Interesting. Either way John Hempton is an uninformed person making silly stupid statements and parading as if he has any medical knowledge. I challenge him or anyone on here to tell me the mechanism of action of fentanyl. Please finance people leave the doctoring and drug judgement to the real professionals.
    3 Feb 2014, 01:07 PM Reply Like
  • Regarded Solutions
    , contributor
    Comments (17900) | Send Message
     
    why should they, the government wont leave the profession alone now!
    3 Feb 2014, 01:08 PM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    Great post as $GALE could rise solely on the effectiveness of Abstral. Thanks for your service and input doc! Please tell these people just what it takes for you to script Abstral or all immediate release fentanyls, do you just see patients for 10 minutes and write out that script & I just run it to the local pharmacy (although, other than the obvious, sometimes I wish it were that easy)? What kind of documentation and risk do you take even if that were a possibility? These people don't understand that for those of us that need and are grateful for Abstral, we no longer receive adequate or any relief from the "usual" breakthrough meds. I believe too much misinformation is out there and I hope Neuvax goes the distance in my lifetime but as posted elsewhere, Subsys was the catalyst for Insys' success.
    3 Feb 2014, 07:22 PM Reply Like
  • stockcatalystsdotcom
    , contributor
    Comments (76) | Send Message
     
    i think this is as usual, the strong trying to get the weak out an get the stock back down.
    3 Feb 2014, 01:08 PM Reply Like
  • Zubunda
    , contributor
    Comments (168) | Send Message
     
    Yeah, especially since INSYS their main competitor in the fantanyl space has the exact same promotion regime, as per my earlier post... Hard to believe that people actually fall for this
    3 Feb 2014, 01:12 PM Reply Like
  • Mr_Bio
    , contributor
    Comments (2) | Send Message
     
    1. Free first month's prescription is very common practice to combat generics in pharma. Is it questionable? sure, but so is the entire pharmaceutical industry. Nature of the beast here, and is pervasive across all companies. Note - this still needs a doctor's belssing with prescription, they aren't just putting a "Take One" sign at pharmacy counters. Horrible misreported in the blog.

     

    2. His claims about NeuVax conveniently leave out the fact that in the phase2, 65% of pts had known suboptimal dosage. Entire study was still very close to significance with p=0.08. Phase 3 is designed around the optimal pop. and dosage, which is report significance, albeit at only p = 0.045. If you're going to claim to subjectively report data, report it ALL, not just what suits your argument. Here's the link to the primary literature: http://bit.ly/1et7Zxk
    http://bit.ly/1et7XFK

     

    Author claimed subgroups were too small to draw conclusions, and attributes success to dumb luck. But accepted stats say you can claim significance at n=30. While it is a small population, it is absolutely significant. The point of using statistics is to weed out experiments and justify them so you CAN'T claim luck.

     

    3. While the magnitude of insider selling is concerning, these were options that were part of the directors' salaries. Any fiscally intelligent person would exercise those options. Ahns' weighted average cost basis was 1.32/shr. If the company succeeds, he will still make incredible money as the CEO. If it fails, he's just covered himself. It's the "all your eggs in one basket" argument. That being said, seeing 1M shares sold is still very concerning.

     

    The money paid to promote the stock in all forms of media is also very concerning to me. But keep in mind they are a small cap developmental company. They should focus on making the best drug possible. This also explains why they accept seemingly poor deals for marketing rights. They don't have the capacity to be both a developmental and commercial company at this point.

     

    Disclosure: Long GALE
    3 Feb 2014, 01:22 PM Reply Like
  • cmcsess
    , contributor
    Comments (124) | Send Message
     
    Not in this fight but this drug is not just handed out to doctors and hospitals as samples but is offered to patients free for one month:

     

    http://bit.ly/1kFNPBR

     

    All a patient has to do is print a voucher and go to a pharmacy with the voucher and their prescription.

     

    Now, I realize that plenty of drug manufacturers offer similar programs but when it's a drug that is already routinely cut with heroin and sold on the street I feel it's irresponsible. It's one thing for a drug dealer to have to find a way to buy or steal a pharmaceutical. But when all you have to do is get a prescription, either phony or from a crooked doctor, print a voucher and find a lax or crooked pharmacy to give it to you, what heroin dealer is not going to try to do that? Just a quick search but here's a story about 8 overdoses in a 24 hour period in Dutchess County, NY. No, not New York City but Upstate, not exactly a hotbed of heroin use:

     

    http://bit.ly/1kFNMWH

     

    If they want to give free samples to cancer patients, great! But there has to be a better way to do it.
    3 Feb 2014, 01:45 PM Reply Like
  • gatlingg
    , contributor
    Comments (380) | Send Message
     
    Just how do you think a cancer patient gets his pain prescription filled? If he is still mobile he takes his prescription to a pharmacy and they fill it.
    For 16 yrs (in the 80's & 90's) as a hospice volunteer I often took these patients to md's & pharmacies but frankly the biggest concern during these years was getting the pain relief these folks desperately needed at a cost they could afford. If I was involved it meant they had another 6-15 weeks left. Having a drug that gave quick relief was not available but would have been greatly desired. Not all the folks I was involved with responded well to opioids. Since my hospice days I have been involved with family & friends as they were dying. It's hard to express my contempt for the folks seeking to make a few bucks shorting a company with disingenuous articles & fake hysteria.
    3 Feb 2014, 06:16 PM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    There is currently a great way to ensure the right patients get these drugs. Google REMS and Fentanyl but I'll read you a tiny excerpt of the program for these specific medications. I feel it's critical for everyone to understand that it's not grabbing a script and filling it, not even close. I'll stick to the facts from FDA.gov or go to http://bit.ly/1cONMlA which controls not only the patient but doctor and pharmacy, all three must be enrolled to receive, script or dispense this type of medication. So you can't take your schedule 2 RX, if you were to get one, & have it filled, again all three are vetted and MUST be enrolled in the program. Per FDA.gov, small exact excerpt:
    Healthcare providers prescribing TIRF medicines for outpatient use are specifically certified.
    To become certified to prescribe TIRF medications, prescribers will be required to enroll in the TIRF REMS program. Prescribers must complete the following requirements to be enrolled:
    You can go to the website to see exactly how many steps must be completed by doctors to simply RX this drug and every other immediate release fentanyl medication, including Subsys. It's quite a list so you must show absolute demonstration for need of this product.
    The only way this drug will ever be diverted which is completely out of any pharmaceutical company's hands, is when mom or grandma dies and there's a few left, whomever's left to care for the patient could do something not so bright. But that's with everything, so tightly regulated. It's not right to make it sound like it's like all narcotics or schedule 2's, hence the strong warnings and the FDA knows exactly who and how much, via these programs, are being taking, where they are filled and WHO is writing these scripts, again only a TIRF registered, educated and approved doctor can even write for Abstral and like medications.
    Which drug do you think pill mills will write for? The one that's thousands and last for 30 minutes and provides no "high" where they will be scrutinized so heavily and patients would likely drop dead from use or the usual Schedule 2's which again, the really sick patients are being punished for due to this type of scripting.
    Medical records w/objective documentation must be submitted to gain access to this drug, only then are you allowed to use a coupon or trial to see if it works for you and again, co-pay assistance cards are used by all pharmaceutical companies because insurers only want to cover older and often less effective drugs. Why else would a patient spend so much on this drug if there are so many other effective CANCER BREAKTHROUGH PAIN MEDICATIONS that are remotely cheaper?
    I'm sorry I know so much about this and hope none of you have to, however, this is important information to include when assessing the motives and value of a company based on the product they offer which in this case is Abstral.
    Thank you
    3 Feb 2014, 06:53 PM Reply Like
  • Bryce_in_TX
    , contributor
    Comments (3610) | Send Message
     
    Morty,

     

    Thank you for your contributions on GALE and Abstral. I am glad it has given you some degree of quality of life back. Hang in there, keep fighting and keep posting.
    4 Feb 2014, 08:47 AM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    Thank you, I will don't you worry! Abstral works, it allowed my to hold my own through all of this and I am eternally grateful.
    4 Feb 2014, 11:25 AM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    Actually it was a hotbed of heroin abuse, the police knew it but only after a high-profile death did we hear about it. It wouldn't take the DEA long to find the "crooked" doctors and "crooked & lying cancer patients" getting this drug and selling it to drug dealers to cut into their heroin. May want to lay off Breaking Bad for a bit.
    10 Feb 2014, 01:59 AM Reply Like
  • jpcmd91
    , contributor
    Comments (3) | Send Message
     
    First of all, Abstral is a superior product to Subsys, Insys Therapeutics' main product for breakthrough cancer pain in that it comes in MUCH less bulky product packaging (making the patients and pharmacists happy), no throw away after administration, takes effect faster (cancer patients prefer this), its a tablet that disintegrates under the tongue in about 30 seconds, and the patients seem to prefer it. Insys Therapeutics was "giving away" their drug last summer with a similar coupon program to Abstral (as many pharma companies do), and their stock went from $6/share to $55+/ share today (the biggest IPO on Wall Street last year apparently). I believe that you will see a similar story with Galena's Abstral drug to Insys' Subsys drug in the next 2 quarters. Abstral sales will go through the roof and market share will greatly increase vs. Subsys, which will further fund Galena's R&D for the cancer vaccines, in my opinion. I am long Galena.
    3 Feb 2014, 03:20 PM Reply Like
  • Zubunda
    , contributor
    Comments (168) | Send Message
     
    Exactly! They (Insys) still have the same promotion going on:
    From INSYS website:
    "Patient Co-Pay Savings Program
    Start saving with the SUBSYS Effective Dose Savings Program. Patients can receive free product and up to $500 off each additional prescription. This program is for commercially insured and cash paying patients only." Source: http://bit.ly/1et4Ld6

     

    The only logical/possible explanation behind this raid is that there are monstruous Abstral sales on the way when GALE reports...
    4 Feb 2014, 03:21 AM Reply Like
  • CalogeroMilan
    , contributor
    Comments (8) | Send Message
     
    Talking about obscenity, what do you think about some people manipulating the price of a stock to make plenty of $$$, at the cost of small investors... If the Abstral news would have come out without all this voices against GALE, the stock would have returned to its highest price; for sure, if you plan to buy lots of this company, it is way better to contrast this natural move...
    3 Feb 2014, 06:24 PM Reply Like
  • deercreekvols
    , contributor
    Comments (6711) | Send Message
     
    This from Bronte Capital's website: http://brontecapital.com

     

    Bronte short sells common stocks as a hedge of our portfolio or for profit including taking small positions in frauds, fads and failures. Generally we will disclose the size and and risk in those positions but (as the investment case is often contingent on fraud) we may refrain from disclosing positions.

     

    ** notice the use of "and and", clearly a typo on the company description-Yikes! **

     

    This from Bronte Capital newsletter, November 2013:

     

    "Given our run in biotech stocks this year, you think we should take seriously Nancy Reagan's famous advice: just say no to drugs."
    "Shorting the hottest stocks in the hottest sectors in a Bull market is not much fun."
    3 Feb 2014, 07:27 PM Reply Like
  • Joseph Poma
    , contributor
    Comments (439) | Send Message
     
    Isn't amazing how SA gives credit to one of its bearish authors when the stock move coincides with a published article, but when the stock takes a bullish turn which coincides with an article publication, SA is mum.... interesting, just making observations....http://seekingalpha.co...
    7 Feb 2014, 10:05 AM Reply Like
  • MortyLong
    , contributor
    Comments (150) | Send Message
     
    Nice bump Friday :))).
    10 Feb 2014, 02:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs